Effect of carnosine on erythrocyte deformability in diabetic rats

References

• Aguirre F, Martin I, Grinspon D, Ruiz M, Hager A, De Paoli T, Ihlo J, Forach A, Poole CP Jr (1998). Oxidative damage, plasma antioxidant capacity, and glucemic control in elderly NIDDM patients. Free Radic Biol Med 24 (4): 580–5.
   PubMed Web of Science ®Google Scholar
• Ahmet AM. (2002). History of diabetes mellitus. Saudi Med J 23:373–8.
   PubMed Web of Science ®Google Scholar
• Alaghband–Zadeh J, Mehdizadeh S, Khan NS, O’Farrel A. (2001). The natural substrate for nitric oxide synthase activity. Cell Biochem 19:277–80.
   Google Scholar
• Allen H, Allen JC, Boyd LC, Alston-Mills BP, Fenner GP. (2006). Determination of membrane lipid differences in insulin resistant diabetes mellitus type 2 in whites and blacks. Nutrition 22:1096–1102.
   PubMed Web of Science ®Google Scholar
• Arto K, Sandra T. (1996). The calcium dependent nitric oxide production of human vascular endothelial cell in preeclampsia. Am J Obstet Gynecol 174:1056–60.
   PubMed Web of Science ®Google Scholar
• Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Işimer A. (2001). Oxidative stress and nitric oxide related paremeters in type II diabetes mellitus: effects of glycemic control. Clin Biochem34:65–70.
   PubMed Web of Science ®Google Scholar
• Aydogan S, Yapislar H, Artis S. (2008). Impaired erythrocyte deformability in H2O2 induced oxidative stress: protective effect of carnosine. Clin Hemorheol Microcirc 39:93–8.
   PubMed Web of Science ®Google Scholar
• Bitar MS, Wahid S, Mustafa S, Saleh E, Dhaunsi G, Mulla F. (2005). Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 511:53–64.
   PubMed Web of Science ®Google Scholar
• Brown C, Ghali H, Zhao Z, Thomas L, Friedman E. (2005). Association of reduced red blood cell deformability with diabeti nephropathy. Kidney Int 67:295–300.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L, Taboga C (1998). Anti-oxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest 28:323–33.
   Google Scholar
• Chiarelli F, Cipollone F, Romano F, Tumini S, Constantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F et al. (2000). Increased circulating nitric oxide in young patients with type I diabetes and persistant microalbuminuria, relation to glomerular hyperfiltration. Diabetes 49:1258–63.
   PubMed Web of Science ®Google Scholar
• Chien S. (1970). Shear dependence of effective cell volume as a determinant of blood viscosity. Science 168:977–9.
   PubMed Web of Science ®Google Scholar
• Chiu DTY, Lubin B, Shohet SB. (1982). Peroxidative reactions in red cell biology. Free Radicals in Biology. New York: Academic Press, 115–60.
   Google Scholar
• Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. (1997). High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cell. Circulation 96:25–8.
   PubMed Web of Science ®Google Scholar
• Craven PA, DeRubertis FR. (1989). Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 83:1667–75.
   PubMed Web of Science ®Google Scholar
• Garnier M, Attali JR, Valensi P. Delatour Hanns E. (1990). Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 38:794.
   Google Scholar
• Giugliano D, Ceriello A, Paolisso G. (1996). Oxidative stress and diabetic vascular complications. Diabetes Care 39:257–267.
   Google Scholar
• Godin DV, Wohaieb SA, Garnett ME, Goumenlouk AD. (1988). Anti–oxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84:223–31.
   PubMed Web of Science ®Google Scholar
• Gupta S, Sussman I, McArthur CS, Tornheim K, Cohen RA, Ruderman NB, (1992). Endothelium dependent inhibition of Na/K ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium derived nitric oxide. J Clin Invest 90:727–32.
   PubMed Web of Science ®Google Scholar
• Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchov M, Thaiss F, Stahl RA, Warnholtz A, et al. (2001). Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:14–22.
   PubMed Web of Science ®Google Scholar
• Hogg N, Kalyanaraman B. (1999). Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1411:378–84.
   PubMed Web of Science ®Google Scholar
• Inouye M, Mio T, Sumino K. (1999). Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism 48:205–9.
   PubMed Web of Science ®Google Scholar
• Jain SJ, Levine SN, Duett J, Hallier B. (1990). Elevated lipid peroxidation levels in red blood cells of streptozotocin treated diabetic rats. Metabolism 39:971–5.
   PubMed Web of Science ®Google Scholar
• Kaneto H, Kajimoto T, Matsuzawa Y, Yamasaki Y, Hori M. (1999). Benefical effects of anti-oxidants in diabetes. Diabetes 48:2398–406.
   PubMed Web of Science ®Google Scholar
• Kanner J, Harel S, Granit R. (1991). Nitric oxide as an anti-oxidant. Arch Biochem Biophys 289:130–36.
   PubMed Web of Science ®Google Scholar
• Kedziora-Kornatowska KA, Luciak M, Blaszczyk Pawlak W. (1998). Lipid peroxidation and activities of anti-oxidant enzymes in erythrocytes of patients with non-insulin depedent diabetes mellitus with of without nephropathy. Nephrol Dial Transplant 13:2829–32.
   PubMed Web of Science ®Google Scholar
• Kekow J, Ulrichs K, Müller-Ruchholtzw W, Gross WL. (1988). Measurement of rat insulin: enzyme-linked immunosorbent assay with increased sensitivity, high accuracy, and greater practicability than established radioimmunoassay. Diabetes 37:321–6.
   PubMed Web of Science ®Google Scholar
• Kiechle F, Malinski T. (1993). Nitric oxide: Biochemistry, pathophysiology and detection. Clin Chem 100:567–75.
   Google Scholar
• Khoschsorur GA, Winklhofer BM, Rabl H, Auer T, Peng Z, Schaur J. (2000). Evaluation of a sensitive HPLC method for the determination of Malondialdehyde, and application of the method to different biological materials. Chromatographia 52:1612–1112.
   Google Scholar
• Korobov VN, Maurisio RB, Mukalov IO, Stvolinski SL. (2000). Carnosine stabilization of the normal erythrocyte membranes and in experimental diabetes. Patol Fiziol Eksp Ter 2:13–15.
   PubMedGoogle Scholar
• Kurealla EG, Maltseva VV, Seslavina LS, Stvolinskii SL. (1991). Stimulating action of carnosine on hematopoietic stem cells. Bull Exp Biol Med 112:966–8.
   Web of Science ®Google Scholar
• Küçükatay MB, Wenby RB, Meiselman HJ, Baskurt OK. (2003). Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 284:1577–84.
   Google Scholar
• Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. (2000). Regulation of endothelial constitutive nitric oxidde synthase gene expresion in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101:676–681.
   PubMed Web of Science ®Google Scholar
• Lo HC, Lin SC, Wayn YM. (2004). The relationship among serum cytokines, chemokine, nitric oxide and leptin in children with type 1 diabetes mellitus. Clin Biochem 37:666–72.
   PubMed Web of Science ®Google Scholar
• Lubin B, Chiu DTY. (1982). Properties of vitamin E-deficient erythrocytes following peroxidant injury. Pediatr Res 16:928–32.
   PubMed Web of Science ®Google Scholar
• Maritim AC, Sanders RA, Watkins III JB. (2003). Diabetes, oxidative stress and anti–oxidants, review. J Biochem Mol Toxicol 17:4–38.
   Google Scholar
• Marjani A. (2010). Lipid peroxidation alterations in type 2 diabetic patients. Pak J Biol Sci 13:723–730
   PubMedGoogle Scholar
• Martinez M, Veya A, Server R, Santaolaria M, Aznar J. (1998). Erythrocyte elongation index measured on a Rheodyn SSD laser diffractometer. Influence of the hematocrit. Clin Hemorheol Microcirc 19:255–7.
   PubMed Web of Science ®Google Scholar
• Maxwell SRJ, Thomason H, Sandler D, Baxter MA, LeGuen C, Baxter MA, Thorpe GL, Jones AF, Barnett AH (1997). Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in NIDDM. Ann Clin Biochem 34:638–644.
   PubMed Web of Science ®Google Scholar
• Mazzanti L, Faloia E, Rabini RA, Staffolani R, Kantar A, Fiorini R, Swoboda B, De Pirro R, Bertoli El. (1992). Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. Clin Biochem 25:41–46.
   PubMed Web of Science ®Google Scholar
• Mohan A, Srinivasan V, Deepa R, Mohan V. (2001). Lipoprotein (a): role in diabetes and its vascular complications. J Assoc Physicians India 49:1100–105.
   PubMedGoogle Scholar
• Mokken FH, Kaderia M, Henny CP, Haredeman MR, Gelb AW. (1992). The clinical importance of erythrocyte deformability, a hemorheological parameter. Ann Hematol 64:113–22.
   PubMed Web of Science ®Google Scholar
• Mol MJ, Rijke YB, Demecker PN, Stalenhoef AF. (1997). Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129:169–76.
   PubMed Web of Science ®Google Scholar
• Paolisso G, D’Amore A, Balbi V, Volpe C, Galzerano D, Giugliano D, Sgambato S, Varricchio M, D’Onofrio F. (1994). Plasma vitamin C affects glucose homeostasis in healthy subjects and in NIDDM. Am J Physiol 266:261–268.
   PubMed Web of Science ®Google Scholar
• Prokopieva VD, Bohan NA, Johnson P, Abe H, Boldyrev AA. (2000). Effects of carnosine and related compounds on the stability and morphology of erythrocytes from alcoholics. Alcohol Alcoholism 35:44–8.
   PubMed Web of Science ®Google Scholar
• Quinn PJ, Boldyrev AA, Formazuyk VE. (1992). Carnosine: its properties, function and potential therapeutic applications. Mol Aspects Med 13:379–444.
   PubMed Web of Science ®Google Scholar
• Rabini RA, Fumelli P, Staffolani R, Mazzanti L, Pugnaloni A, Biagini G, Faloia F, De Pirro R. (1993). Effect of diabetes mellitus on structural and functional properties of erythrocyte membranes. Membr Biochem 10:71–79.
   PubMed Web of Science ®Google Scholar
• Rubbo H, Batthyhany C, Radi R. (2000). Nitric oxide-oxygen radicals interactions in atherosclerosis. Biol Res 33:167–75.
   PubMed Web of Science ®Google Scholar
• Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ. (1999). Lipid peroxidation and anti-oxidant enzyme activities in patients with type I diabetes mellitus. Scand J Clin Lab Invest 59:99–105.
   PubMed Web of Science ®Google Scholar
• Schemetterer L, Findl O, Fasching P, Ferber W, Strenn K, Breiteneder H, Adam H, Eichler HG, Wolzt M. (1997). Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 46:653–8.
   PubMed Web of Science ®Google Scholar
• Shin S, Ku YH, Suh JS, Singh M. (2008). Rheological characteristics of erythrocytes incubated in glucose media. Clin Hemorh and Microcirc 38:153–61.
   PubMed Web of Science ®Google Scholar
• Singh VP, Jam NK, Kulkarni SK. (2003). Fluoxetine suppresses morphine tolerance and dependence: Modulation of NO-cGMP/DA/serotoninergic pathways. Methods Find Exp Clin Pharmacol 25:273–80.
   PubMed Web of Science ®Google Scholar
• Smits P, Hersbach FMRJ, Jansen TLTA, Thien J, Lutterman JA. (1993). Impaired vasodilator response to atrial natriuretic factor in IDDM. Diabetes 42:1454–61.
   PubMed Web of Science ®Google Scholar
• Szkudelski T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:536–46.
   Web of Science ®Google Scholar
• Sun MF, Wen YR, Kua PL, Liu CF. (2005). Elevated nitric oxide levels inhibit malondialdehyde production in patients with diabetes mellitus in Taiwan. Nutr Met Car Dis 15:452–3.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Nakashima Y, Toda K. (2009). Carnosine facilitates nitric oxide production in endothelial f-2 cells. Biol Pharm Bull 32:1836–9.
   PubMed Web of Science ®Google Scholar
• Tavazzi B, Pierro D, Amorini AM, Fezzina G, Tuttobene M, Giardina B. (2000). Energy metabolism and lipid peroxidation of human erythrocytes as a function of increased oxidative stress. Eur J Biochem 267:684–9.
   PubMedGoogle Scholar
• Testa I, Mantrini S, Gregorio A, Refe A, Bonfigli AR, Testa R, Piantanelli L. ((2003)). Red blood cell deformability in diabetic retinopahty. Biorheology 32:389.
   Google Scholar
• Tomonaga S, Tachibana T, Takahashi H, Sato M, Denbow DM, Furuse M. ((2005)). Nitric oxide involves in carnosine induced hyperactivity in chicks. Eur J Pharmacol 524:84–88.
   PubMed Web of Science ®Google Scholar
• Vague P, Dufayet D, Lamotte M, Mouchot C, Raccah D. (1992). Genetic factors, Na+/K+-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy. Diabetes Metab 18:236–41.
   Web of Science ®Google Scholar
• Vanizor B, Orem A, Karahan SC, Kiran E, Erem C, Aliyazicioglu R, Uydu HA. (2001). Decreased nitric oxide and products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res Clin Prac 54:33–9.
   PubMed Web of Science ®Google Scholar
• van Dam B, Demirci C, Reitsma HJ, van Lambalgen AA, van den Bos GC, Tangelder GJ, Stehouwer CD. (2002). Arteriolar changes in nitric oxide activity and sensitivity during the course of streptozotocin-induced diabetes. Eur J Pharmacol 455:43–51.
   PubMed Web of Science ®Google Scholar
• Varvarovska J, Racek J, Stozicky F, Soucek L, Trefil R. (2003). Parameters of oxidative stress in children with type I diabetes mellitus and their relatives. J Diabetes Complications 17:7–10.
   PubMed Web of Science ®Google Scholar
• Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. (1996). Abnormal anti-oxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetic Med 13:715–19.
   PubMed Web of Science ®Google Scholar
• Weed RI. (1970). The importance of erythrocyte deformability. Am Jour Med 49:147–50.
   PubMed Web of Science ®Google Scholar
• Wolff SP, Dean RT. (1987). Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J 245:245–50.
   Google Scholar
• Yang ZC, Xia K, Wang L, Jia SJ, Li D, Zhang Z, Deng S, Zhang XH, Deng HW, Li YJ. (2007). Asymmetric dimethylarginine reduced erythrocyte deformability in streotozotocin–induced diabetic rats. Microvasc Res 73:131–136.
   PubMed Web of Science ®Google Scholar
• Yapislar H, Aydogan S, Borlu M, Ascioglu O. (2007). Decreased nitric oxide and increased platelet aggregation levels in patients with Behçet’s disease. Thromb Res 119:461–465.
   PubMed Web of Science ®Google Scholar